|
|
H2014/CTD1977/469
|
ANDARAN HCT
|
IRBESARTAN AND HYDROCHLOROTHIAZIDE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2014/CTD1978/470
|
ANDARAN HCT
|
IRBESARTAN AND HYDROCHLOROTHIAZIDE
|
NVS KENYA LTD
|
Withdrawn
|
Details →
|
|
|
15103
|
IROVEL H TABLETS
|
IRBESARTAN AND HYDROCHLOROTHIAZIDE
|
SUN PHARMA EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
15103/R1
|
IROVEL H TABLETS
|
Irbesartan and Hydrochlorothiazide
|
Sun Pharmaceutical Industries Limited
|
Retained
|
Details →
|
|
|
H2003/273/15103/R1
|
IROVEL H TABLETS
|
Irbesartan and Hydrochlorothiazide
|
Sun Pharmaceutical Industries Limited
|
Retained
|
Details →
|
|
|
H2022/CTD4974/1299ER
|
IRBIS-HT 300/12.5
|
IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLETS 300 MG/12.5 MG
|
UNISEL LTD
|
Registered
|
Details →
|